Literature DB >> 15819808

Microbial surveillance during human pancreatic islet isolation.

Pascal Bucher1, Jose Oberholzer, Domenico Bosco, Zoltan Mathe, Christian Toso, Leo H Bühler, Thierry Berney, Philippe Morel.   

Abstract

The aim of the study was to investigate microbiological contamination rate during human pancreatic islet isolation. Between 1996 and 2002, pancreas preservation media and post-purification islet preparations were screened for microbiological contamination. After arrival in the laboratory, pancreata were washed prior to enzyme perfusion with either Hank's balanced salt solution (Group I, n = 170, 1996 to 2001) or decontaminated with polyvidonum-iodine, cefazoline, and amphotericine B (Group II, n = 45, 2001 to 2002). Microbiological contamination of preservation media was observed in 56% and 84% for Groups I and II, respectively. Analysis of contaminants revealed 74% Gram-positive, 21% Gram-negative bacteria and 5% fungi. Duration of transport had an influence on the rate of contamination (P < 0.05). After islet isolation, Group I presented microbial contamination of 16 islet preparations (9.4%) [i.e. Gram-positive bacteria (n = 10), Gram-negative bacteria (n = 4), and fungi (n = 2)]. In Group II, only 2 islet preparations (4.4%) presented microbial contamination. Microbial contamination during pancreas procurement occurs frequently. Most microorganisms are eliminated during islet isolation, and de novo contaminations during islet isolation are rare. Pancreas decontamination reduces the risk of infection of the final islet preparation.

Entities:  

Mesh:

Year:  2005        PMID: 15819808     DOI: 10.1111/j.1432-2277.2005.00092.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  7 in total

1.  Microbial contamination of clinical islet transplant preparations is associated with very low risk of infection.

Authors:  Boris Gala-Lopez; Tatsuya Kin; Doug O'Gorman; Andrew R Pepper; Peter Senior; Atul Humar; A M James Shapiro
Journal:  Diabetes Technol Ther       Date:  2013-02-25       Impact factor: 6.118

2.  Early Infectious Complications After Total Pancreatectomy with Islet Autotransplantation: a Single Center Experience.

Authors:  Justyna E Gołębiewska; Piotr J Bachul; Natalie Fillman; Mark R Kijek; Lindsay Basto; Monica Para; Laurencia Perea; Karolina Gołąb; Ling-Jia Wang; Martin Tibudan; Alicja Dębska-Ślizień; Jeffrey B Matthews; John Fung; Piotr Witkowski
Journal:  J Gastrointest Surg       Date:  2019-02-04       Impact factor: 3.452

3.  Use of the BacT/alert system for rapid detection of microbial contamination in a pilot study using pancreatic islet cell products.

Authors:  Laura Murray; Neil McGowan; John Fleming; Laura Bailey
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

4.  Infectious complications of pancreatic islet transplantation: clinical experience and unanswered questions.

Authors:  Stephanie M Pouch
Journal:  Curr Infect Dis Rep       Date:  2015-05       Impact factor: 3.725

5.  Failure mode and effect analysis in human islet isolation: from the theoretical to the practical risk.

Authors:  Quentin Perrier; Vanessa Lavallard; Nadine Pernin; Charles-Henri Wassmer; David Cottet-Dumoulin; Fanny Lebreton; Kevin Bellofatto; Axel Andres; Ekaterine Berishvili; Domenico Bosco; Thierry Berney; Géraldine Parnaud
Journal:  Islets       Date:  2021-02-22       Impact factor: 2.694

6.  Prophylactically Decontaminating Human Islet Product for Safe Clinical Application: Effective and Potent Method.

Authors:  Meirigeng Qi; Keiko Omori; Yoko Mullen; Brian McFadden; Luis Valiente; Jemily Juan; Shiela Bilbao; Bernard R Tegtmeier; Donald Dafoe; Fouad Kandeel; Ismail H Al-Abdullah
Journal:  Transplant Direct       Date:  2016-02

7.  Improvement of the functionality of pancreatic Langerhans islets via reduction of bacterial contamination and apoptosis using phenolic compounds.

Authors:  Mahban Rahimifard; Shermineh Moini-Nodeh; Kamal Niaz; Maryam Baeeri; Hossein Jamalifar; Mohammad Abdollahi
Journal:  Iran J Basic Med Sci       Date:  2018-09       Impact factor: 2.699

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.